[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
[ Fri, Aug 02nd 2024 ]: WOPRAI
Gregory Renza Maintained (AGIO) at Buy with Increased Target to $55 on, Aug 2nd, 2024
Gregory Renza of RBC Capital, Maintained "Agios Pharmaceuticals, Inc." (AGIO) at Buy with Increased Target from $53 to $55 on, Aug 2nd, 2024.
Gregory has made no other calls on AGIO in the last 4 months.
There are 3 other peers that have a rating on AGIO. Out of the 3 peers that are also analyzing AGIO, 2 agree with Gregory's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Tessa Romero of "JP Morgan" Initiated at Hold and Held Target at $46 on, Thursday, June 13th, 2024
- Salveen Richter of "Goldman Sachs" Maintained at Hold with Increased Target to $53 on, Tuesday, June 4th, 2024
This is the rating of the analyst that currently disagrees with Gregory
- Eric Schmidt of "Cantor Fitzgerald" Reiterated at Buy on, Monday, June 17th, 2024